Literature DB >> 17881

Stress-induced alterations of cyclic nucleotide levels in brain: effects of centrally acting drugs.

V Dinnendahl, S W Gumulka.   

Abstract

Acute stressing procedures cause a shortlasting increase in the levels of guanosie 3',5'-monophosphate (cGMP) in mouse brain without significantly influencing the concentrations of adenosine 3'-5'-monophosphate (cAMP). Animals were pretreated with various centrally acting drugs before being stressed in order to study the involvement of specific neurotransmitters in the stress-induced rise of cGMP levels. Centrally depressant drugs affecting different synaptic mechanisms, such as chlorpromazine, reserpine, haloperidol, diazepam, and pentobarbital, inhibited the cCMP increase elicited by stress. Pretreatment with atropine, diphenhydramine, antazoline, cyproheptadine, phentolamine, bunitrolol, and indomethacin had no significant effect. Clonidine and both the (-)- and (+)-isomers of propranolol inhibited the stress-induced cGMP increase in a dose-related manner. Our results suggest that norepinephrine, serotonin, acetylcholine, or prostaglandins are not involved in the elevation of cGMP levels elicited by acute stress. Participation of other neurotransmitter(s), such as dopamine or GABA, cannot be excluded.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 17881     DOI: 10.1007/BF00426707

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  32 in total

Review 1.  The role of cyclic nucleotides in central synaptic function.

Authors:  F E Bloom
Journal:  Rev Physiol Biochem Pharmacol       Date:  1975       Impact factor: 5.545

2.  Effect of immobilization stress on serotonin content and turnover in regions of the rat brain.

Authors:  W W Morgan; P K Rudeen; K A Pfeil
Journal:  Life Sci       Date:  1975-07-01       Impact factor: 5.037

3.  Possible involvement of central histamine H2-receptors in the hypotensive effect of clonidine.

Authors:  H Karppanen; I Paakkari; P Paakkari; R Huotari; A L Orma
Journal:  Nature       Date:  1976-02-19       Impact factor: 49.962

4.  Effects of amphetamine, chlorpromazine and reserpine on cyclic GMP and cyclic AMP levels in mouse cerebellum.

Authors:  J A Ferrendelli; D A Kinscherf; D M Kipnis
Journal:  Biochem Biophys Res Commun       Date:  1972-03-24       Impact factor: 3.575

5.  A rapid and simple procedure for the determination of guanosine 3',5'-monophosphate by use of the protein-binding method.

Authors:  V Dinnendahl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

6.  Tranquillizing effects of propranolol demonstrated in rats.

Authors:  J G Bainbridge; D T Greenwood
Journal:  Neuropharmacology       Date:  1971-07       Impact factor: 5.250

7.  Pharmacological effects of two new -adrenoceptor blocking drugs: Kö 1366 and Kö 1313.

Authors:  G Cheymol; C Honnorat; H Schmitt
Journal:  Eur J Pharmacol       Date:  1972-03       Impact factor: 4.432

8.  Reduction of level of L-glutamic acid decarboxylase by gamma-aminobutyric acid in mouse brain.

Authors:  P Y Sze; R A Lovell
Journal:  J Neurochem       Date:  1970-12       Impact factor: 5.372

9.  Effects of dopaminergic stimulants on cyclic nucleotide levels in mouse brain in vivo.

Authors:  S W Gumulka; V Dinnendahl; H D Peters; P S Schönhöfer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976       Impact factor: 3.000

10.  Effects of stimulatory and depressant drugs on cyclic guanosine 3',5'-monophosphate and adenosine 3',5'-monophosphate levels in mouse brain.

Authors:  F A Opmeer; S W Gumulka; V Dinnedahl; P S Schönhöfer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976       Impact factor: 3.000

View more
  3 in total

1.  On the mode of action of clonidine: relationship between effects on behaviour and cyclic nucleotide content in mouse brain.

Authors:  S W Gumulka; V Dinnendahl; D Bartmus; P S Schönhöfer; K Stock
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-05       Impact factor: 3.000

2.  The effect of naloxone on cerebellar cGMP content. A possible GABA-antagonistic action?

Authors:  S W Gumulka; V Dinnendahl; P S Schönhöfer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-03       Impact factor: 3.000

3.  An evaluation of the selectivity of fenmetozole (DH-524) reversal of ethanol-induced changes in central nervous system function.

Authors:  G D Frye; G R Breese; R B Mailman; R A Vogel; M G Ondrusek; R A Mueller
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.